Company: Blue Cross Blue Shield of Massachusetts
Job title: VP, Clinical Programs & Strategy
Dr. Katherine Dallow is Vice President and Medical Director, Clinical Programs and Strategy for Blue Cross Blue Shield of Massachusetts (BCBSMA).
Throughout her career, Dr. Dallow has held executive leadership positions within both health plans and accountable care organizations. Prior roles have included Vice President of Clinical Affairs and Quality for Blue Cross & Blue Shield of Rhode Island (BCBSRI) and Medical Director for Managed Care for the Beth Israel Deaconess Care Organization (BIDCO). She is an experienced physician executive and leader with a proven track record in value based contract management, quality metrics analysis and performance, practice pattern variation analysis, pharmacy cost management, high risk care management and care coordination, and risk adjustment.
She is a board certified internal medicine physician who practiced for 15 years in the Beth Israel Deaconess system in Boston and several of its surrounding suburban communities. She earned a Masters in Public Health in health care policy and management from the Harvard School of Public Health, a medical degree from Jefferson Medical College of Thomas Jefferson University in Philadelphia, and a Bachelor’s of Arts in English and American Studies from Princeton University.
Dr. Dallow also serves as Chair of the New England Chapter of the American Diabetes Association Community Leadership Board.
Shifting Payment Paradigms: How One-Time High Cost Treatments Challenge the Traditional U.S. Payer Model 11:00 am
Gaining insights into the unique challenges gene therapies pose to the classical payer model Providing a framework for how payers need to consider the balance between access and affordability in the context of innovative but expensive therapeutics Understanding the traditional stop loss financing model for high cost cases and how that model is not sustainable…Read more
day: Track D - Day 1 am
Panel Discussion: How Can Patients, Advocacy Groups and Companies Work More Effectively with Payers? 5:00 pm
Including the patient voice to educate and inform payers with real-life experiences from patient advocates Understanding the implications of reimbursement strategies on patients and the wider family Contrasting the discussions in indications with existing therapeutic options and those with a lack of treatment optionsRead more
day: Day Two